What are the most effective interventions in adults with PTSD?

26 Mar 2020
What are the most effective interventions in adults with PTSD?

In the treatment of post-traumatic stress disorder (PTSD), eye movement desensitization and reprocessing (EMDR) and trauma-focused cognitive behavioural therapy (TF-CBT) appear to be most effective at reducing symptoms and increasing remission rates as well as sustaining symptom improvements after therapy has ended, according to the results of a meta-analysis.

Researchers conducted a systematic review of trials evaluating psychological, psychosocial and other nonpharmacological interventions targeted at clinically important post-traumatic stress symptoms in adults >1 month following a traumatic event. Another outcome assessed was remission post-treatment.

The network meta-analysis included 90 trials, involving 6,560 participants and 22 interventions. Evidence was of moderate-to-low quality.

For reducing PTSD symptoms, the following interventions ranked the best relative to waitlist: EMDR (standardised mean difference [SMD], −2.07, 95 percent credible interval [CrI] −2.70 to −1.44), combined somatic/cognitive therapies (SMD, −1.69, 95 percent CrI, −2.66 to −0.73), TF-CBT (SMD, −1.46, 95 percent CrI, −1.87 to −1.05), and self-help with support (SMD, −1.46, 95 percent CrI, −2.33 to −0.59). These were followed by non-TF-CBT, TF-CBT combined with a selective serotonin reuptake inhibitor (SSRI), SSRIs, self-help without support, and counselling.

Notably, the improvements achieved with EMDR and TF-CBT were sustained at 1–4-month follow-up.

In terms of remission, EMDR, TF-CBT, self-help with support, and counselling were associated with higher rates post-treatment. Results for other interventions were either inconclusive or based on limited evidence.

More studies are warranted to explore the long-term comparative effectiveness of psychological therapies for adults with PTSD, as well as to establish the impact of severity and complexity of PTSD on treatment outcomes, according to the researchers.

Psychol Med 2020;doi:10.1017/S0033291720000070